NS-3623
CAS No. 343630-41-1
NS-3623 ( NS 3623;NS3623 )
Catalog No. M14170 CAS No. 343630-41-1
A novel human RBC Cl-conductance blocker (IC50=210 nM) and HERG channel activitor (EC50=79.4 uM, HERG1 channel activation).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 72 | Get Quote |
|
10MG | 115 | Get Quote |
|
25MG | 237 | Get Quote |
|
50MG | 385 | Get Quote |
|
100MG | 575 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNS-3623
-
NoteResearch use only, not for human use.
-
Brief DescriptionA novel human RBC Cl-conductance blocker (IC50=210 nM) and HERG channel activitor (EC50=79.4 uM, HERG1 channel activation).
-
DescriptionA novel human RBC Cl-conductance blocker (IC50=210 nM) and HERG channel activitor (EC50=79.4 uM, HERG1 channel activation); inhibits RBC g(Cl) after oral administration to normal mice (ED50= 25 mg/kg), ameliorates erythrocyte dehydration in transgenic SAD mice; increases the macroscopic current conducted by the hERG channels by increasing the time constant for channel inactivation; affects native I(Kr), decreases QT variability and distinctly decreases the occurrence of extrasystoles in the acutely bradypaced hearts.Anemia Discontinued
-
SynonymsNS 3623;NS3623
-
PathwayCell Cycle/DNA Damage
-
TargetPotassium Channel
-
RecptorPotassium Channel
-
Research AreaOther Indications
-
IndicationAnemia
Chemical Information
-
CAS Number343630-41-1
-
Formula Weight427.19
-
Molecular FormulaC15H10BrF3N6O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NC1=CC=CC(C(F)(F)F)=C1)NC2=CC=C(Br)C=C2C3=NNN=N3
-
Chemical NameN-(4-bromo-2-(1H-tetrazol-5-yl)-phenyl)-N'-(3'-trifluoromethylphenyl)urea
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Bennekou P, et al. Blood. 2001 Mar 1;97(5):1451-7.
2. Hansen RS, et al. Mol Pharmacol. 2006 Oct;70(4):1319-29.
3. Hansen RS, et al. J Pharmacol Exp Ther. 2007 Jun;321(3):996-1002.
4. Hansen RS, et al. J Cardiovasc Pharmacol. 2008 Jul;52(1):35-41.
2. Hansen RS, et al. Mol Pharmacol. 2006 Oct;70(4):1319-29.
3. Hansen RS, et al. J Pharmacol Exp Ther. 2007 Jun;321(3):996-1002.
4. Hansen RS, et al. J Cardiovasc Pharmacol. 2008 Jul;52(1):35-41.
molnova catalog
related products
-
QO-40
QO-40 is a KCNQ2/3 potassium channels activator.QO-40 potently augmented KCNQ2/3 channels expressed in Chinese hamster ovary cells and shifted the half-maximal activation voltage (V(1/2)) in the hyperpolarizing direction.?The V(1/2) was negatively shifted in a concentration-dependent manner.?
-
NS6180
NS6180 is a novel potent and selective KCa3.1 channel inhibitor(IC50= 9 nM) prevents T-cell activation and inflammation.
-
AVE-0118
AVE-0118 is a potent I(to)/I(Kur) blocker, Kv1.5 channel inhibitor with IC50 of 5.6 uM.